Company profile: Sense Biodetection
1.1 - Company Overview
Company description
- Provider of molecular diagnostics, developing novel, user-centered handheld tests for infections and oncology, including Veros COVID-19, an instrument-free rapid COVID-19 test delivering results in about 15 minutes at the point of care without the need for specialized laboratory equipment.
Products and services
- Handheld Infection Tests: Engineers novel, user-centred handheld molecular diagnostic tests for infections, focused on improving healthcare decisions and processes
- Handheld Oncology Tests: Architects novel, user-centred handheld molecular diagnostic tests in oncology, focused on improving healthcare decisions and processes
- Veros COVID-19: A rapid, instrument-free COVID-19 test that delivers results in about 15 minutes, designed for point-of-care use without specialized laboratory equipment
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sense Biodetection
AnimalBiome
HQ: United States
Website
- Description: Provider of microbiome-focused pet health solutions for dogs and cats, including gut health test kits for stool-based microbiome analysis, gut restore supplements with healthy bacteria, gut maintenance products with prebiotics and probiotics, oral health products with prebiotic action, a State of the Gut report with dietary and exercise recommendations, and microbiome research partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AnimalBiome company profile →
Gentris
HQ: United States
Website
- Description: Provider of global pharmacogenomic testing and biorepository services, helping pharmaceutical companies and clinical research organizations integrate pharmacogenomics into drug development to deliver safer, more effective compounds to market more quickly.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gentris company profile →
Counsyl
HQ: United States
Website
- Description: Provider of DNA screening for men, women, and their children, focusing on diseases where advanced knowledge can improve health outcomes, whether by changing behavior, pursuing preventative measures, or preparing for what lies ahead.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Counsyl company profile →
TissueGene
HQ: United States
Website
- Description: Provider of regenerative biopharmaceutical therapies for orthopedic disorders, offering TG-C, an allogeneic cell and gene therapy designed to treat knee osteoarthritis by reducing pain, improving function, and slowing disease progression.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TissueGene company profile →
iGenomX
HQ: United States
Website
- Description: Provider of DNA sequencing technology advancing NGS library preparation to enable clinical sequencing for recessive genetic disorders and detect all genetic variation, addressing limitations of commercial tests that miss nearly 30 percent of known causal mutations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iGenomX company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sense Biodetection
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sense Biodetection
2.2 - Growth funds investing in similar companies to Sense Biodetection
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sense Biodetection
4.2 - Public trading comparable groups for Sense Biodetection
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →